Bausch & Lomb: Stocks Analysts Recently Downgraded on TSX (BLCO)
Bausch & Lomb is among the group of Toronto Stock Exchange stocks recently downgraded by analysts. This means each stock on this list has seen its averge consensus value drop in the last week so at least one analyst has downgraded their view on these stocks.
This report is generated monthly. It displays the number of analysts along with their buy-hold-sell ratings for the company. A company is included in this list when its mean rating decreases from the previous week. Stocks in this category are generally sold to preserve capital. Companies can get downgraded for a number of reasons - but primarily due to reduced future earnings potential due to loss of contracts, new faltering product lines or increasing costs relative to revenue or financial risk.
| Symbol | Name | Buy | Out Perform | Hold | Under Perform | Sell | No Opinion | Mean Rating | Previous Mean Rating | Mean Label |
|---|---|---|---|---|---|---|---|---|---|---|
| BBD-A-T | Bombardier Inc | 6 | 2 | 0 | 0 | 0 | 0 | 4 | 4 | Buy |
| BLCO-T | Bausch & Lomb Corp | 3 | 0 | 1 | 0 | 0 | 0 | 4 | 5 | Outperform |
| PRV-UN-T | PRO Real Estate Investment Trust | 2 | 1 | 3 | 0 | 0 | 0 | 3 | 4 | Outperform |
| CCO-T | Cameco Corp | 2 | 4 | 0 | 0 | 0 | 0 | 4 | 4 | Outperform |
| ERO-T | Ero Copper Corp | 3 | 3 | 5 | 0 | 0 | 0 | 3 | 3 | Outperform |
| BBD-B-T | Bombardier Inc | 6 | 2 | 0 | 0 | 0 | 0 | 4 | 4 | Buy |
More about Bausch & Lomb Corp
Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and v
Artificial intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
